Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (688180 CH)
Watchlist
46
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
07 Apr 2021 17:51
Junshi Biological H Share Announcement (君实生物H股公告)
Attachment
Exchange Announcement •
28 Feb 2021 16:50
Junshi Bio Voluntarily Disclosed The Announcement On Signing An Exclusive Promotion Agreement With Astrazeneca Pharmaceuticals (君实生物自愿披露关于与阿斯利康制药签署独家推广协议的公告)
Attachment
Exchange Announcement •
26 Feb 2021 16:10
Junshi Biology 2020 Annual Results Express Announcement (君实生物2020年度业绩快报公告)
Attachment
Exchange Announcement •
24 Feb 2021 18:53
Junshi Biological Announcement On Voluntary Disclosure Of Pd-1/Tgf-Β Bifunctional Fusion Protein Js201 Injection To Obtain Drug Clinical Trial Application Acceptance Notice (君实生物自愿披露关于Pd-1/Tgf-Β双功能融合蛋白Js201注射液获得药物临床试验申请受理通知书的公告)
Attachment
Exchange Announcement •
17 Feb 2021 16:26
Junshi Biological Voluntary Disclosure Announcement On The Fda Approval Of The Clinical Trial Application For Anti-Tigit Monoclonal Antibody Injection (君实生物自愿披露关于抗Tigit单抗注射液临床试验申请获得Fda批准的公告)
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x